88 results
Page 4 of 5
10-K
lxnxa0y7ylftxwyv2ir
16 Mar 20
Annual report
11:09am
10-K
EX-10.1
wj5qezrswlqzm0 4gv9b
16 Mar 20
Annual report
11:09am
8-K
EX-99.1
33sck98z2n0cxw7a
7 Nov 19
Regulation FD Disclosure
4:01pm
DEF 14A
sf15ilpn
1 Oct 19
Definitive proxy
6:07am
8-K
EX-10.1
6fnkony
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-1.1
3uc45p1 g7oxw67ows1
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
424B5
mfaufp3ui0 k6x6sgl
27 Sep 19
Prospectus supplement for primary offering
4:14pm
8-K
EX-10.1
g2u jagmyk2hd7bx54
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
424B5
9gj65qfg2ck
5 Aug 19
Prospectus supplement for primary offering
9:08am
8-K
EX-1.1
xggsqq 2m
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-10.1
zqipzcqgvkqvs n0pjq
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
424B5
3v7ir8ncs nyyz7fn
2 Aug 19
Prospectus supplement for primary offering
4:28pm
S-3/A
EX-4.9
o4wsjcsoz0nxk
26 Jun 19
Shelf registration (amended)
12:00am
S-3/A
djt0u kng
26 Jun 19
Shelf registration (amended)
12:00am
S-3
hzw9tfcgph3uubf
21 Jun 19
Shelf registration
5:29pm
S-8
EX-4.7
r9m1mpfp m0dcl
21 Jun 19
Registration of securities for employees
5:04pm
8-K
EX-10.1
mdipiygxuur
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
8-K
EX-4.1
kc3znns8gj95
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
8-K
EX-99.1
zkldyd8
19 Jun 19
Regulation FD Disclosure
9:31am